TMX Newsfile

IN THE PRESS

Drug Development

InFlectis BioScience awarded $650K grant from the National Multiple Sclerosis Society to advance IFB-048 preclinical development in Multiple Sclerosis; Research to be Performed by Prof. Popko of Northwestern University

April 30, 2024

·

2 min read

Policy

Justera Addresses Delay on Annual Filings

April 29, 2024

·

3 min read

Business

Justera Announces Changes to Management

April 29, 2024

·

3 min read

Biosenta Closes Private Placement Financing

April 29, 2024

·

3 min read

Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model

April 29, 2024

·

6 min read

NervGen Engages Russo Partners LLC to Provide Public Relations Services

April 25, 2024

·

4 min read

Defence’s AccuTOX Anti-Cancer ARM-002 Vaccine Exhibits Potent Antigen Presentation

April 23, 2024

·

4 min read

Biosenta Announces Private Placement Financing

April 22, 2024

·

3 min read

BioMark Announces Warrant Extension and Granting of Options

April 18, 2024

·

3 min read

NervGen Pharma Reports 2023 Year-End Financial Results and Operational Updates

April 17, 2024

·

12 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750